Augmented region of interest for untargeted metabolomics mass spectrometry (AriumMS) of multi-platform-based CE-MS and LC-MS data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Augmented region of interest for untargeted metabolomics mass spectrometry (AriumMS) of multi-platform-based CE-MS and LC-MS data ; volume:415 ; number:16 ; day:25 ; month:5 ; year:2023 ; pages:3137-3154 ; date:7.2023
Analytical and bioanalytical chemistry ; 415, Heft 16 (25.5.2023), 3137-3154, 7.2023
- Urheber
-
Naumann, Lukas
Haun, Adrian
Höchsmann, Alisa
Mohr, Michael
Novák, Martin
Flottmann, Dirk
Neusüß, Christian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00216-023-04715-6
- URN
-
urn:nbn:de:101:1-2023092508130938863103
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Naumann, Lukas
- Haun, Adrian
- Höchsmann, Alisa
- Mohr, Michael
- Novák, Martin
- Flottmann, Dirk
- Neusüß, Christian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Filtering procedures for untargeted LC-MS metabolomics data
LC-MS
LC-MS and GC-MS based metabolomics platform for cancer research
LC-MS, MS-Analyse von Eicosanoiden
Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics
Effect of soil factors on flavonoid metabolites in Striga asiatica using LC–MS based on untargeted metabolomics
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics
Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements
Metabolomics characterization of two saffron from Iran and China using GC–MS and LC–MS methods
Filtering procedures for untargeted LC-MS metabolomics data
LC-MS
LC-MS and GC-MS based metabolomics platform for cancer research
LC-MS, MS-Analyse von Eicosanoiden
Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics
Effect of soil factors on flavonoid metabolites in Striga asiatica using LC–MS based on untargeted metabolomics
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics
Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements
Metabolomics characterization of two saffron from Iran and China using GC–MS and LC–MS methods
Filtering procedures for untargeted LC-MS metabolomics data
LC-MS
LC-MS and GC-MS based metabolomics platform for cancer research
LC-MS, MS-Analyse von Eicosanoiden
Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics
Effect of soil factors on flavonoid metabolites in Striga asiatica using LC–MS based on untargeted metabolomics
Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
Entwicklung von Screeningverfahren für Arzneistoffe und Metaboliten mittels LC-MS und LC-MS-MS
MetaboAnalystR 4.0: a unified LC-MS workflow for global metabolomics
Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements